(MENAFN- PR Newswire) DUBLIN, June 8, 2023 /PRNewswire/ --
The "ivd market trends report - 2023" report has been added to ResearchAndMarkets.com's offering.
The analyst continues to be diligent in outlining the IVD market and it's rapidly changing landscape. The analyst has been and continues to be superior in accessing the market due to the extensive experience of its analysts and the commitment of the company to present the most accurate data available.
Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine.
Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient.
Ultimately, the IVD market remains dynamic, demonstrating constant innovations.
In IVD Market Trends Report, March 2023, the analyst analyses and answers:
What's Driving Growth in the IVD Market since Q1 2022 and into Q1 2023? What Major Trends have been Affecting the Market since Q1 2022 and into Q1 2023? How Has COVID-19 Impacted and Continued to Impact the Market? What Product Trends and New Developments Will Shape the IVD Market?
Key Topics Covered:
Chapter 1: Worldwide IVD Market - March 2023 Update
IVD Market Demand and Growth COVID-19 Diagnostic Markets Effect of COVID-19 on Market Segments
Chapter 2: Product Trends and New Developments
Selected New - Q4 2022 and Q1 2023 - Core IVD Product Launches, Developments and Trends Immunoassay Molecular Personalized Medicine POC Sequencing Selected COVID-19 Developments - Q4 2022 - Q1 2023 Antigen/Antibody Molecular
Chapter 3: Top IVD Market Participant Results
Selected Competitive Leader Updates IVD Segment Growth by Leading Competitors (Abbott Diagnostics, Becton Dickinson, bioMerieux, Danaher, Hologic, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific), Change in Sales, 2021-2022 2022 M&A Activity Abbott Laboratories Becton Dickinson and Co bioMerieux SA Danaher Corporation Hologic, Inc. QuidelOrtho Corporation Roche Diagnostic Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific
Chapter 4: New Opportunities
Artificial Intelligence Future Trends At-Home Testing Multiplex Testing Telehealth
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo:
SOURCE Research and Markets
MENAFN08062023003732001241ID1106411730
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.